The global blood screening market is expected to reach a value of USD 3.9
billion by 2024, based on a new report by Grand View Research, Inc. The growth
of the market is attributed to the increasing screening of donor and continuous
technological advancements by the market players. Demand for blood screening
tests are increasing continuously due to increasing donation, rising awareness
about transfusion-transmitted diseases, and technological developments in the
industry.
Thorough screening is necessary for all donated blood to ensure that
recipients receive the safest products. As of 2015, such testing consists of
screening for red cell antibodies, and the infectious diseases agents: HIV-1,
HIV-2, hepatitis virus, West Nile Virus (WNV), Human T-Lymphotropic Virus
(HTLV) T. Cruzi, and T. pallidum (syphilis). Result of all these assays must be
negative for blood donation.
Technological developments in the market increase the sensitivity and
efficiency of the tests. For instance, in 2016, the U.S. FDA approved the
Procleix Zika virus assay from Hologic, Inc. and Grifols to screen donated
blood. Furthermore, the U.S. FDA approved next-generation sequencing (NGS)
technology in 2013. The technology is cheaper and faster than previous DNA
analysis methods.
In depth research report on Blood Screening Market
Further Key Findings from the Study Suggest:
·
Nucleic acid amplification test or nucleic acid test (NAT)
is expected to be the fastest growing segment during the forecast period. It
comprises transcription mediated amplification (TMA) tests and polymerase chain
reaction. Increasing demand of NAT over ELISA test due to high sensitivity and
specificity for viral nucleic acid is contributing to the fastest growth during
the forecast period.
·
In 2015, reagent dominated the product segment.
Introduction of new assays for the detection of various diseases is expected to
enable the segment to gain the maximum share of market in the coming years. For
instance, in January 2015 the FDA approved Roche’s blood screening assay COBAS
TaqScreen MPX Test for the detection and identification of HCV, HIV, and HBV.
·
In 2015, regionally North America dominated with a revenue
share of more than 40%. Government initiatives, presence of major players, and
more patient affordability are the major factors that contributed toward its
dominance.
·
In August 2016, the FDA recommended the testing of all the
donated blood in the U.S. and its territories for Zika virus in order to
prevent transmission of this virus through the blood supply.
·
Asia Pacific is expected to be the fastest growing region
due to increasing investment of industry players, government initiatives, and
rising awareness about transmission of diseases during its transfusion.
·
The Red Cross in Japan entered into a contract with
Grifols for nucleic acid testing (NAT) for a blood donation camp in Japan in
2014. This agreement is anticipated to propel the NAT market during the
forecast period. However, low donation as compared to requirement and high cost
of kits and instruments are likely to restrain the growth in low-income
countries during the forecast period.
Grand View Research has segmented the blood screening market by
technology, product and region:
Blood Screening Market
Technology Outlook (Market Revenue in USD Million, 2013 - 2024)
·
Nucleic Acid Amplification Test (NAT)
·
ELISA
Chemiluminescence
Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
·
Next-Generation Sequencing (NGS)
·
Western Blotting
Blood Screening Market
Product Outlook (Market Revenue in USD Million, 2013 - 2024)
·
Reagent
·
Instrument
Blood Screening Market
Regional Outlook (Market Revenue in USD Million, 2013 - 2024)
·
North America
o
U.S.
o
Canada
·
Europe
o
UK
o
Germany
·
Asia Pacific
o
Japan
o
China
·
Latin America
o
Brazil
o
Middle East and Africa
·
South Afric
Browse more research reports of this category:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San
Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
For more market analysis
reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment